Table 2 Clinical characteristics of patients after treatment

Age^* (years)

15.1 ± 1.12^a

16.1 ± 0.94^ac

14.8 ± 1.10^c

 < 0.05

Bone age^*(years)

15.2 ± 0.53^ab

14.1 ± 0.47^a

14.3 ± 0.45^b

 < 0.05

HtSDS-CA^*

0.12 ± 0.65

0.03 ± 0.34^c

0.39 ± 0.47^c

 < 0.05

HtSDS-BA^*

-0.14 ± 0.18^ab

0.60 ± 0.29^a

0.51 ± 0.24^b

 < 0.05

Duration (months)

24.9 ± 4.47^a

34.1 ± 3.36^ac

22.7 ± 2.49^c

 < 0.05

Height^*(cm)

169.8 ± 0.83

171.2 ± 0.81

170.6 ± 0.75

 > 0.05

AHt

170.9 ± 0.7^ab

173.5 ± 1.0^a

173.2 ± 1.5^b

 < 0.05

AHtSDS

-0.29 ± 0.1^ab

0.07 ± 0.2^a

0.09 ± 0.2^b

 < 0.05

IGF-1^* (nmol/L)

62.1 ± 19.6^b

74.6 ± 23.4

80.9 ± 20.8^b

 < 0.05

TSH^* (mIu/L)

1.92 ± 0.96

1.65 ± 0.57

1.69 ± 0.77

 > 0.05

T4^* (Pmol/L)

15.9 ± 2.2

14.5 ± 3.1

15.7 ± 3.2

 > 0.05